B · Normal On November 21, Novo Nordisk's Sogroya® was approved by the US FDA, becoming the first and only once-weekly long-acting growth hormone for children with Turner syndrome. Novo Nordisk 🕐 2026-11-21 01:01 #Novo Nordisk 🖼️ Save as Image Generate a beautiful long image to share on Moments or in group chats Generate now ⬇ Share 🔗Copy Link 📘Facebook 🐦X (Twitter) 💬WhatsApp 💼LinkedIn 👽Reddit ← Back to Telegraph
Comments